CircSipa1l1 Modulates Melanoma Cell Differentiation by Activating the IGF2BP1-ARHGDIB Axis and ERK Signaling Pathway

Investigators revealed that circSipa1l1 acts as an oncogenic circRNA by regulating the IGF2BP1/ARHGDIB/ERK axis in melanoma, suggesting it could be a potential therapeutic target for melanoma differentiation therapy.